Contribution of nitric oxide to reactive hyperemia impact of endothelial dysfunction

Hypertension

Volumn 32, Issue 1, 1998, Pages 9-15

  Dakak, Nader ^a   Husain, Syed ^a   Mulcahy, David ^a   Andrews, Neil P ^a   Panza, Julio A ^a   Waclawiw, Myron ^a   Schenke, William ^a   Quyyumi, Arshed A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Atherosclerosis; Endothelium; Hyperemia; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ARGININE; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPEREMIA; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MICROVASCULATURE; PRIORITY JOURNAL; REPRODUCIBILITY; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0031927113     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.1.9     Document Type: Article

References (61)

1. Bache RJ, Cobb FR, Greenfield JC Jr. Limitation of the coronary vascular response to ischemia in the awake dog. Circ Res. 1974;35:527-535.
2. Dornhorst AC, Whelan RF. The blood flow in muscle following exercise and circulatory arrest: the influence of reduction in effective local blood pressure, of arterial hypoxia, and of adrenaline. Clin Sci. 1953;12:33-40.
3. Dunn RB, McDonough KM, Griggs DM Jr. High energy phosphate stores and lactate levels in different levels of the canine left ventricle during reactive hyperemia. Circ Res. 1979;44:788-795.
4. Kontos HA, Mauck HP Jr, Patterson JL Jr. Mechanism of reactive hyperemia in limbs of anesthetized dogs. Am J Physiol. 1965;209: 1106-1114.
5. Olsson RA. Kinetics of myocardial reactive hyperemia blood flow in the unanesthetized dog. Circ Res. 1964;15(suppl I):81-86.
6. Olsson RA, Snow JA, Gentry MK. Adenosine metabolism in canine myocardial reactive hyperemia. Circ Res. 1978;42:358-362.
7. Carlsson I, Wennmalm A. Effect of different prostaglandin synthesis inhibitors on post-occlusive blood flow in human forearms. Prostaglandins. 1983;26:241-251.
8. Carlsson I, Sollevi I, Wennmalm A. The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperemia. J Physiol. 1987;389:147-161.
9. Bockman EL, Berne RM, Rubio R. Adenosine and active hyperemia in dog skeletal muscle. Am J Physiol. 1976;230:1531-1537.
10. Aversano T, Ouyang P, Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res. 1991;69:618-622.
11. Lombard JH, Duling BR. Multiple mechanisms of reactive hyperemia in arterioles of the hamster cheek pouch. Am J Physiol. 1981;241 (Heart Circ Physiol 10):H748-H755.
12. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO III. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest. 1995;95:1747-1755.
13. Koller A, Kaley G. Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. Circ Res. 1990; 67:529-534.
14. Koller A, Kaley G. Role of endothelium in reactive dilation of skeletal muscle arterioles. Am J Physiol. 1990;259(Heart Circ Physiol 28): H1313-H1316.
15. + current in vascular endothelial cells. Nature. 1988;331: 168-170.
16. Kanatsuka H, Sekiguchi N, Sato K, Akai K, Wang Y, Komaru T, Ashikawa K, Takishima T. Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart. Circ Res. 1992;71:912-922.
17. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
18. Casino PR, Kilcoyne CM, Quyyumi A, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
19. Pohl U, Busse R. Hypoxia stimulates release of endothelium-derived relaxant factor. Am J Physiol. 1989;25:H1595-H1600.
20. Kelm M, Freelisch M, Deussen A, Schrader J, Strauer BE. The role of nitric oxide in the control of coronary vascular tone in relation to partial oxygen pressure, perfusion pressure, and flow. J Cardiovasc Pharmacol. 1991;17:95-99.
21. Lamontagne D, Pohl U, Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res. 1992;70:123-130.
22. Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol. 1990;259:H804-H812.
23. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependem vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
24. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87: 1468-1474.
25. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
26. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
27. Quyyumi AA, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia: comparison of acetylcholine and substance P. Circulation. 1997;95:104-110.
28. Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO III. Impaired release of nitric oxide from atherosclerotic human coronary vasculature. J Am Coll Cardiol. 1997;29:308-317.
29. Egashira K, Inou T, Hirooka Y, Yamade A, Maruoka Y, Kai H, Sugimachi M, Suzuki J, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:29-37.
30. Drexler H, Zeiher AM, Meinertz T, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1550.
31. Creager MA, Girerd XJ, Gallagher SH, Coleman S, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90:1248-1253.
32. Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T, Takeshita A. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension. 1992;20:511-517.
33. Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, Sherez J, Blum M, Laniado S, Iaina A, Keren G. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol. 1995;26: 1251-1256.
34. Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms. Circulation. 1996;94:130-134.
35. Quyyumi AA, Dakak N, Diodati J, Gilligan DM, Panza JA, Cannon RO III. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol. 1997;30:1220-1227.
36. Dubois-Randé J-L, Zelinsky R, Roudot F, Chabrier PE, Castaigne A, Gerschwind H, Adnot S. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol. 1992; 70:1269-1275.
37. Hussain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation. 1998; 97:716-720.
38. Lindsay DC, Holdright DR, Clarke D, Anand IS, Poole-Wilson PA, Collins P. Endothelial control of lower limb blood flow in chronic heart failure. Heart. 1996;75:469-476.
39. Segal J, Sheehan D, Corl PD, Nassi M, Starksen N, Ford AJ Jr, Webber M. A Doppler guidewire used to assess coronary flow during PTCA in humans. Circulation. 1990;82(suppl III):III-622. Abstract.
40. Wolin MS, Rodenburg JM, Messina FJ, Kaley G. Similarities in the pharmacological modulation of reactive hyperemia and vasodilation to hydrogen peroxide in rat skeletal muscle arterioles: effects of probes for endothelium-derived mediators. J Pharmacol Exp Ther. 1990;253:508-512.
41. Yamabe H, Okumura K, Ishizaka H, Tsuchiya T, Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Physiol. 1992;263:H8-H14.
42. Parent R, Paré R, Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol. 1992;262: H10-H16.
43. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res. 1992;70:208-212.
44. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91: 1314-1319.
45. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90:2285-2290.
46. Chu A, Chambers DE, Lin C-C, Kuehl WD, Palmer RMJ, Moncada S, Cobb FR. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest. 1991;87:1964-1968.
47. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. The contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation. 1994;90:2853-2858.
48. Folkow B. Resistance to blood flow at maximal vasodilation. Hypertension. 1988;12:635-637.
49. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
50. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
51. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87: 1468-1474.
52. Cox DA, Vita JA, Treasure CB, Fish RD, Alexander RW, Ganz OP, Selwyn AP. Atherosclerosis impairs flow-mediated dilatation of coronary arteries in humans. Circulation. 1989;80:458-465.
53. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol. 1990;16:349-356.
54. Quyyumi AA, Dakak N, Andrews NP, Gilligan DM, Panza JA, Cannon RO III. Contribution of nitric oxide to metabolic vasodilation in the human heart. Circulation. 1995;92:320-326.
55. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 1991;83:1057-1062.
56. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients. J Am Coll Cardiol. 1994;23: 844-850.
57. Panza JA, Casino PR, Badar DM, Quyyumi AA. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation: abnormal response in patients with essential hypertension. Circulation. 1993;87:1475-1481.
58. Hirooka Y, Egashira K, Imaizumi T, Tagawa T, Kai H, Sugimi M, Takeshita A. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans. J Am Coll Cardiol. 1994;24:948-955.
59. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol. 1995; 26:1054-1061.
60. Clarkson P, Adams MR, Powe AJ, Donald AE, Mc Credie R, Robinson J, McCarthy SN, Keech A, Celermajer DS, Deanfield JE. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 1996;97:1989-1994.
61. Giugliano D, Marfella R, Verrazzo G, Acampora R, Coppola L, Cozzolino D, D'Onofrio F. The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest. 1997;99:433-438.